It might be difficult to try at different dosages as you can’t just start at a higher dose - you do have to start small and work up. I had side effects every time I increased my dose - terrible nerve pain all over my body at night and horrendous dreams. You are supposed to stay at each new dose for two or three weeks before increasing again. Then at some point you go past your limit and have to come back down until you find the right dose.A practical question that comes up in the context of an LDN trial is dosing. Titrating the dose up to find a best dose is very difficult to combine with a randomised fully blinded controlled design.
The simplest option would be just to try four different dose levels. The next thing might be to move up through about three doses on a monthly basis but then you hit statistical problems I think, in that people will expect to get better later. Any dosing that produces side effects regularly would damage blinding. I don't know what has been done in the past in this sort of situation. It cannot be entirely new as a problem.
There are documents that have been put together on the Facebook group that describe why this is. I can get them and post here if anyone wants them.
There are numerous resources on the page but a lot are posted and not documents. I can go through tomorrow on the pc and copy them into documents and send them to you. Or if you want to join the group is called:It would be useful to know if there is any knowledge about mechanisms and schedules.
If the dose has to be increased slowly because of side effects then I think blinding becomes pretty well impossible. If so I think the only option is to do a fix schedule study to see if benefit can be shown statistically at lower dosages and then, knowing that there is some useful effect, to do an open titrating study with as strictly objective an outcome measure as possible. If the benefit is just a shift in symptoms that is going to be tricky.
Or if you want to join the group is called:
![]()
We are particularly lucky you have joined us here.I don't have an account for Facebook and am glad I don't. Sometimes it limits things but for various reasons I think it best for me not to join!
Maybe for the same reason it is such a blessing that I never joined Twitter - for everyone.
The UK government working party on research strategy for ME has been discussing the value of setting up trials for drug repurposing.
if you’re looking at drug repurposing for currently available approved drugs, better candidates would be low doses of the dopamine stabilizers/dopamine partial agonists.
My reason for not trying it was that I typically take a dose of tramadol for nighttime pain at least twice a week, which works well and doesn't have any side effects. It makes a big difference to my QoL, so I decided that swopping it for something which might or might not be effective against nighttime pain and seemed more likely to come with side effects, wasn't ideal. (Opiate-related meds apparently aren't compatible with LDN.)
I'm not severely affected, though, and I'm lucky enough to have the mobility equipment I need to be able to get out of the house some of the time; this affects the risk/benefit calculation too.
Yes, unfortunately facebook has stopped allowing some documents to be edited and any more to be created so we can’t update them any longer so we just post info in discussions. I think people tend to read them there more anyway. I don’t know that people read documents all that much with low energy.There are numerous resources on the page but a lot are posted and not documents. I can go through tomorrow on the pc and copy them into documents and send them to you. Or if you want to join the group is called:
View attachment 18839
if you’re looking at drug repurposing for currently available approved drugs, better candidates would be low doses of the dopamine stabilizers/dopamine partial agonists.
Abiliify, Rexulti (Brexpiprazole), vraylar (cariprazine), and possibly Piribedil. These drugs are likely to help patients to a greater extent than LDN.
Any particular reason to think that?
How does the person know that the improvement isn't a fluctuation in illness caused by something else?For one teenager dosing took around 12 months to hit a sweet spot ,and whilst still severely affected , sleep quality ( not quantity) and GI motility has improved and concentration improved such that an online art course is now possible.
At the risk of going off-topic, my PEM and that of many others here involves pain. I describe my pain when in PEM as like being crushed. It might be like the 'bone-crushing pain' that you get when you have the flu. ME/CFS is more than just fatigue. Mister Person, you might like to check out some of the discussion threads on PEM and other symptoms in https://www.s4me.info/forums/symptoms-and-signs-discussions.197/ - you could ask your questions there.I believe there must be some link between my PEM and ME PEM, but I can't say for sure that it's the same. Bc pain is pain... And fatigue is fatigue...
You and I may be in the same boat then eh... I don't know what my pain is, its not achey, and it jumps around. It's not quite what I imagine nerve pain to be, but it's certainly not physical pain. I've never experienced anything like it. Ain't nociplastic either.I have severe FM (re: number of body regions producing pain). I would term a flareup in symptoms PEM quite often. There is a corresponding exhausion/feeling sick/cognitive dysfunction that occurs when pain levels are high, and stress impacts are high, also
I think there is an overlap in some areas between ME/CFS and FM. I do not experience cognitive dysfunction or orthostatic hypotension half the time (diagnostic criteria in a latest iteration) or at least I think I don't (I may be wrong about the cognitive dysfunction!) so I don't qualify, per se, for an ME/CFS diagnosis. However, reading posts here and getting support are very important and helpful to me.